4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001617541-25-000005
Options or other derivatives
- Director acquired 76,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Dorton Katina Director | 2025-10-17 | Grant or award · Director Stock Option (Right to Buy) | +76,000 | 76,000 | D | ||
Loading xslF345X05/primarydocument.xml…